Insider trades

Scott M. Rocklage, 10% Owner of Skye Bioscience SKYE, has filed 2 purchases and 27 sales on the open market. Over the past 12 months that comes to a net sale of $2M. The latest trade was on 09/23.

Scott M. Rocklage

10% Owner
First filing
23/03/09
Trades
29 trades
Buys / sales
2 / 27
12-month net buying
−$2M
Last trade
09/23

Trading activity

Transactions

Trade type
SKYE
Open-market sale09/22–09/2309/24148,079 sh4 trades$1.62avg.$239,555.19−100.0%
Open-market sale25/11/1425/11/18200,000 sh$8.80$1,760,000−6.3%
SKYE
Open-market sale25/08/21–25/08/2225/08/22231,405 sh4 trades$3.46avg.$800,548.5−80.1%
TRDA
Open-market sale25/07/0925/07/1127,000 sh2 trades$7.50avg.$202,500No record
TRDA
Open-market sale25/06/27–25/07/0125/07/01125,000 sh6 trades$6.93avg.$866,500No record
SKYE
Open-market sale24/09/11–24/09/1324/09/13266,337 sh6 trades$6.57avg.$1,750,352.22−80.1%
Open-market buy24/03/1324/03/15450,000 sh$10.00$4,500,000+5.7%
Open-market buy24/01/3124/02/025,206,074 sh$2.31$12,026,030.94+190.2%
Open-market sale23/04/1023/04/1216,544,113 sh3 trades$0.12avg.$1,985,293.56−98.8%
Open-market sale23/03/0723/03/09100,000 sh$8.20$820,000−4.0%